F2RL3 methylation in blood DNA is a strong predictor of mortality

International Journal of Epidemiology

Volumn 43, Issue 4, 2014, Pages 1215-1225

  Zhang, Yan ^a   Yang, Rongxi ^a,b   Burwinkel, Barbara ^a,b   Breitling, Lutz P ^a   Holleczek, Bernd ^c   Schöttker, Ben ^a   Brenner, Hermann ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c SAARLAND CANCER REGISTRY   (Germany)

Author keywords

F2RL3 methylation; Mortality; PAR 4; Prospective study; Smoking

Indexed keywords

DNA; PROTEINASE ACTIVATED RECEPTOR 4; PROTEASE-ACTIVATED RECEPTOR 4; THROMBIN RECEPTOR;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; DNA METHYLATION; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; HUMAN; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MORTALITY; NEOPLASM; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; COHORT ANALYSIS; GENETIC EPIGENESIS; GENETICS; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL;

AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HUMANS; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, THROMBIN; SMOKING;

EID: 84905668302     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyu006     Document Type: Article

References (45)

1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442.
2. Centers for Disease Control and Prevention (USA), National Center for Chronic Disease Prevention and Health Promotion (USA), Office on Smoking and Health (USA). How tobacco smoke causes disease: The biology and behavioral basis for smoking-attributable disease: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (USA), 2010.
3. Mathers C, Stevens G, Mascarenhas M. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva: World Health Organization, 2009.
4. Gellert C, Schöttker B, Brenner H. Smoking and all-cause mortality in older people: systematic review and meta-analysis. Arch Intern Med 2012;172:837-44.
5. Breitling LP, Yang R, Korn B, Burwinkel B, Brenner H. Tobacco-smoking-related differential DNA methylation: 27K discovery and replication. Am J Hum Genet 2011;88:450-57.
6. Wan ES, Qiu W, Baccarelli A et al. Cigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the human genome. Hum Mol Genet 2012;21:3073-82.
7. Shenker NS, Polidoro S, van Veldhoven K et al. Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking. Hum Mol Genet 2013;22:843-51.
8. Sun YV, Smith AK, Conneely KN et al. Epigenomic association analysis identifies smoking-related DNA methylation sites in African Americans. Hum Genet 2013;132:1027-37.
9. Xu WF, Andersen H, Whitmore TE et al. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci U S A 1998;95:6642-46.
10. KahnML, Nakanishi-MatsuiM, ShapiroMJ, IshiharaH, Coughlin SR. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 1999;103:879-87.
11. Wu CC, Teng CM. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombininduced human platelet activation. Eur J Pharmacol 2006;546: 142-47.
12. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature 2000;407:258-64.
13. Kataoka H, Hamilton JR, McKemy DD et al. Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells. Blood 2003;102:3224-31.
14. Vergnolle N, Derian CK, D'Andrea MR, Steinhoff M, Andrade-Gordon P. Characterization of thrombin-induced leukocyte rolling and adherence: a potential proinflammatory role for proteinase-activated receptor-4. J Immunol 2002;169:1467-73.
15. Steinhoff M, Buddenkotte J, Shpacovitch V et al. Proteinaseactivated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev 2005;26:1-43.
16. Ando S, Otani H, Yagi Y et al. Proteinase-activated receptor 4 stimulation-induced epithelial-mesenchymal transition in alveolar epithelial cells. Respir Res 2007;8:31.
17. Dabek M, Ferrier L, Roka R et al. Luminal cathepsing and protease-activated receptor 4: a duet involved in alterations of the colonic epithelial barrier in ulcerative colitis. Am J Pathol 2009;175:207-14.
18. Gratio V, Walker F, Lehy T, Laburthe M, Darmoul D. Aberrant expression of proteinase-activated receptor 4 promotes colon cancer cell proliferation through a persistent signaling that involves Src and ErbB-2 kinase. Int J Cancer 2009;124:1517-25.
19. Black PC, Mize GJ, Karlin P et al. Overexpression of proteaseactivated receptors-1,-2, and-4 (PAR-1, -2, and -4) in prostate cancer. Prostate 2007;67:743-56.
20. Zhang Y, Yu G, Jiang P, Xiang Y, Li W, Lee W. Decreased expression of protease-activated receptor 4 in human gastric cancer. Int J Biochem Cell Biol 2011;43:1277-83.
21. Kaufmann R, Rahn S, Pollrich K et al. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4. J Cell Physiol 2007;211:699-707.
22. Chen HT, Tsou HK, Tsai CH et al. Thrombin enhanced migration and MMPs expression of human chondrosarcoma cells involves PAR receptor signaling pathway. J Cell Physiol 2010;223:737-45.
23. Schö ttker B, Müller H, Rothenbacher D, Brenner H. Fasting plasma glucose and HbA(1c) in cardiovascular risk prediction: a sex-specific comparison in individuals without diabetes mellitus. Diabetologia 2013;56:92-100.
24. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
25. Breitling LP, Salzmann K, Rothenbacher D, Burwinkel B, Brenner H. Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease. Eur Heart J 2012;33:2841-48.
26. Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med 2010;29:1037-57.
27. Therneau TM, Grambsch PM, Fleming TR. Martingale-based residuals for survival models. Biometrika 1990;77:147-60.
28. Lin D, Wei L, Ying Z. Check the Cox model with cumulative sums of martigale-based residuals. Biometrika 1993;80:557-52.
29. Bian C, Wu Y, Shi Yet al. Predictive value of the relative lymphocyte count in coronary heart disease. Heart Vessels 2010;25: 469-73.
30. Zhang Y, Yang R, Burwinkel B, Breitling LP, Brenner H. F2RL3 methylation as a biomarker of current and lifetime smoking exposures. Environ Health Perspect 2013. doi: 10.1289/ehp. 1306937.
31. Rahman MM, Laher I. Structural and functional alteration of blood vessels caused by cigarette smoking: an overview of molecular mechanisms. Curr Vasc Pharmacol 2007;5:276-72.
32. Leone A. Smoking, haemostatic factors, and cardiovascular risk. Curr Pharm Des 2007;13:1661-67.
33. Leger AJ, Covic L, Kuliopulos A. Protease-activated receptors in cardiovascular diseases. Circulation 2006;114:1070-77.
34. Borissoff JI, Spronk HM, ten Cate H. The hemostatic system as a modulator of atherosclerosis. N Engl J Med 2011;364: 1746-60.
35. Dorsam RT, Gutkind JS. G-protein-coupled receptors and cancer. Nat Rev Cancer 2007;7:79-94.
36. Zeilinger S, Kühnel B, Klopp N et al. Tobacco smoking leads to extensive genome-wide changes in DNA methylation. PLoS One 2013;8:e63812.
37. Petersen AK, Zeilinger S, Kastenmüller G et al. Epigenetics meets metabolomics: an epigenome-wide association study with blood serum metabolic traits. Hum Mol Genet 2013. doi: 10.1093/ hmg/ddt430.
38. LaCroix AZ, Lang J, Scherr P et al. Smoking and mortality among older men and women in three communities. N Engl J Med 1991;324:1619-25.
39. Doll R, Peto R, Boreham J, Sutherland I. Mortality from cancer in relation to smoking: 50 years observations on British doctors. Br J Cancer 2005;92:426-29.
40. Ezzati M, Henley SJ, Thun MJ, Lopez AD. Role of smoking in global and regional cardiovascular mortality. Circulation 2005;112:489-97.
41. Ezzati M, Henley SJ, Lopez AD, Thun MJ. Role of smoking in global and regional cancer epidemiology: current patterns and data needs. Int J Cancer 2005;116:963-71.
42. Wu HC, Delgado-Cruzata L, Flom JD et al. Global methylation profiles in DNA from different blood cell types. Epigenetics 2011;6:76-85.
43. Adalsteinsson BT, Gudnason H, Aspelund T et al. Heterogeneity in white blood cells has potential to confound DNA methylation measurements. PLoS One 2012;7:e46705.
44. Smith MR, Kinmonth AL, Luben RN et al. Smoking status and differential white cell count in men and women in the EPICNorfolk population. Atherosclerosis 2003;169:331-37.
45. Reinius LE, Acevedo N, Joerink M et al. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS One 2012; 7:e41361.